samedan logo
 
 
spacer
home > epc > winter 2001 > the trojan horse of oncology - the role of stealth drug delivery
PUBLICATIONS
European Pharmaceutical Contractor

The Trojan Horse of Oncology - The Role of Stealth Drug Delivery

The word 'cancer' instils fear into most people. One in four people will develop cancer at some point in their life and, given the dismal cure rates for most common cancers, many of those who are diagnosed with some form of the disease will eventually die of it. Fear is often augmented by the knowledge that the relentlessly growing cancer often brings with it pain, suffering and debility.

Far from being 'mindless' automatons, it has been shown that tumour cells employ numerous strategies to promote growth. Complicated mechanisms to switch on growth; vascular endothelial growth factors (VEGF) to create a blood supply as a pipeline to bring nutrients; and pumps such as p-Glycoprotein to get rid of ingested cellular toxins are some of the strategies that have evolved.

While the fight against cancer begins with prevention, once it has developed, permanent eradication of the disease requires all the skills oncologists can muster to outwit the tumour cell and the mechanisms it employs to ensure its continued cellular survival and tumour growth.


Read full article >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Peter Cheverton MBChB, MMed Rad(T), Director of Oncology for Daiichi Pharmaceuticals UK Ltd

Peter Cheverton is an Oncologist who spent 20 years in clinical practice before joining the pharmaceutical industry in 1990. He has worked for Lederle, ASTA Medica and has been Director of Oncology for Daiichi Pharmaceuticals UK Ltd for over three years. Peter works in European oncology development as part of the Daiichi Global Oncology Programme.

spacer
Dr Peter Cheverton
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

PharmaBrand Summit 2010

21-23 June 2010, Montreux, Switzerland

The PharmaBrand Summit 2010 offers the perfect setting for sponsors to present their products and services directly to key decision makers from Europe’s leading pharmaceutical, bio- and medical technology companies. Over three days, sponsors will meet and interact with senior-level marketing executives, through a number of business one-to-one meetings and many networking activities. In addition, sponsors will attend the strategic summit sessions led by some of the most prominent thinkers and practitioners in Europe and beyond.
More info >>

 
News and Press Releases

Total Expands Again As Packaging Innovation Hub Grows

Total Processing & Packaging 2010 has increased its floor space for a second time as companies continue to sign up for the UK’s largest processing and packaging exhibition. Due to the high level of demand, organisers Reed Exhibitions have now made another 745.5m² available.
More info >>

 

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement